XI’AN, China, Aug. 11 /Xinhua-PRNewswire-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc , a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production, today announced that it has signed a major supply agreement with DNP International Co., Inc. of Santa Fe Springs, CA.
Under the terms of the agreement Huifeng is to deliver 62 metric tons of Glucuronolactone, a naturally occurring chemical compound which has become a popular additive to energy drinks, over the next six months to DNP. The total dollar amount of the contract is in excess of USD $1.1 Million.
Huifeng anticipates signing additional bi-annual contracts with DNP upon successful completion of the first agreement.
''Our agreement with DNP further demonstrates the increasing international acceptance of Huifeng products. With quality and consistency as our hallmarks, we are now becoming recognized by major US corporations for the quality and consistency of the products we develop and manufacture,’' stated company CEO Jing’An Wang. ''We are pleased to be making further inroads into the US market and hope to sign similar supply agreements with DNP and other US entities in the near future.’'
About Glucuronolactone
Glucuronolactone is a naturally occurring chemical compound produced by the metabolism of glucose in the human liver. It is an important structural component of nearly all connective tissues. The most common usage for Glucuronolactone is in many energy drinks. Because most of these drinks also contain caffeine, Glucuronolactone is included because it is purported to fight fatigue and provide a sense of well-being. According to “The Merck Index” (14th edition) it is also used as detoxicant. (From Wikipedia)
About DNP International
DNP International imports and distributes raw material ingredients to manufacturers in the nutritional supplements, food, beverage, feed, cosmetics and pharmaceutical industries. Founded in 1994, DNP is one of the largest suppliers of raw materials in the United States and sources over 2,500 different ingredients. http://www.dnpint.com/
About Huifeng Bio-Pharmaceutical Technology, Inc. (HFGB)
Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi’an, People’s Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. http://www.hfgb.cn/
CONTACT: Dan Carlson of Primary Capital LLC, DCarlson@PrimaryLLC.com, or
Kelly Black, CEO of Premier Media Services, Inc., +1-480-649-8224, both for
Huifeng
Web site: http://www.hfgb.cn/
http://www.dnpint.com/
